Detalles de la búsqueda
1.
New hopes in relapsed refractory primary central nervous system lymphoma.
Curr Opin Oncol
; 35(5): 364-372, 2023 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37551946
2.
Prevention and management of secondary central nervous system lymphoma.
Haematologica
; 108(3): 673-689, 2023 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36384246
3.
Autologous hematopoietic cell transplantation versus whole-brain radiotherapy consolidation in primary central nervous system lymphoma: A systematic review and meta-analysis.
Hematol Oncol
; 41(1): 88-96, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-36192141
4.
Clinicopathologic characteristics and treatment of marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma).
CA Cancer J Clin
; 66(2): 153-71, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-26773441
5.
CNS prophylaxis for diffuse large B-cell lymphoma.
Lancet Oncol
; 23(9): e416-e426, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-36055310
6.
Impact of severe acute respiratory syndrome coronavirus-2 infection on the outcome of primary central nervous system lymphoma treatment: A study of the International PCNSL Collaborative Group.
Br J Haematol
; 199(4): 507-519, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-35945164
7.
Characteristics and clinical outcomes of patients with ALK-positive anaplastic large cell lymphoma: Report from the prospective international T-cell lymphoma project.
Hematol Oncol
; 40(5): 953-961, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-36083035
8.
A dose-dense short-term therapy for human immunodeficiency virus/acquired immunodeficiency syndrome patients with high-risk Burkitt lymphoma or high-grade B-cell lymphoma: safety and efficacy results of the "CARMEN" phase II trial.
Br J Haematol
; 192(1): 119-128, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33085777
9.
MYD88 L265P mutation and interleukin-10 detection in cerebrospinal fluid are highly specific discriminating markers in patients with primary central nervous system lymphoma: results from a prospective study.
Br J Haematol
; 193(3): 497-505, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33620087
10.
Predicting outcomes in CNS lymphoma with ctDNA.
Blood
; 143(6): 478-480, 2024 Feb 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-38329774
11.
R-CHOP preceded by blood-brain barrier permeabilization with engineered tumor necrosis factor-α in primary CNS lymphoma.
Blood
; 134(3): 252-262, 2019 07 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-31118164
12.
Short regimen of rituximab plus lenalidomide in follicular lymphoma patients in need of first-line therapy.
Blood
; 134(4): 353-362, 2019 07 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-31101627
13.
Induction therapy with the MATRix regimen in patients with newly diagnosed primary diffuse large B-cell lymphoma of the central nervous system - an international study of feasibility and efficacy in routine clinical practice.
Br J Haematol
; 189(5): 879-887, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-31997308
14.
Metabolic heterogeneity on baseline 18FDG-PET/CT scan is a predictor of outcome in primary mediastinal B-cell lymphoma.
Blood
; 132(2): 179-186, 2018 07 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-29720487
15.
Long-lasting efficacy and safety of lenalidomide maintenance in patients with relapsed diffuse large B-cell lymphoma who are not eligible for or failed autologous transplantation.
Hematol Oncol
; 38(3): 257-265, 2020 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-32356913
16.
NGR-TNF Engineering with an N-Terminal Serine Reduces Degradation and Post-Translational Modifications and Improves Its Tumor-Targeting Activity.
Mol Pharm
; 17(10): 3813-3824, 2020 10 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32805112
17.
PD-1/PD-L1 expression and interaction by automated quantitative immunofluorescent analysis show adverse prognostic impact in patients with diffuse large B-cell lymphoma having T-cell infiltration: a study from the International DLBCL Consortium Program.
Mod Pathol
; 32(6): 741-754, 2019 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-30666052
18.
Rituximab in primary central nervous system lymphoma-A systematic review and meta-analysis.
Hematol Oncol
; 37(5): 548-557, 2019 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-31418878
19.
Lymphomas associated with chronic hepatitis C virus infection: A prospective multicenter cohort study from the Rete Ematologica Lombarda (REL) clinical network.
Hematol Oncol
; 37(2): 160-167, 2019 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-30726562
20.
Dosage of high-dose methotrexate as CNS prophylaxis in DLBCL: A detailed analysis of toxicity and impact on CNS relapse.
Am J Hematol
; 99(2): E46-E50, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38037530